Autopsy report · NCT05586126

AnaConDa-therapy in COVID-19 Patients

Cause of deathSafety Automatic label, confidence 0.9, unverified. How labels are made.

“Concerns about possible association between drug and increased ICU mortality”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months after it had already started.
Ran for about 1 year 9 months before it stopped.
42 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Jeroen Bosch Ziekenhuis
Sponsor type: University, hospital or other
Conditions: COVID-19; SARS CoV-2
Interventions: Sevoflurane
Participants: 42
Sites: 1
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.